DAVITA_(UK)_TRADING_LTD - Accounts


Company registration number 07700242 (England and Wales)
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
COMPANY INFORMATION
Directors
J Hemminger
K Singh
M Dhaliwal
J Guerra De Almeida
(Appointed 9 September 2022)
Company number
07700242
Registered office
Unit 11
Greenlea Park
Prince Georges Road
London
SW19 2JD
Auditor
Mercer & Hole LLP
21 Lombard Street
London
EC3V 9AH
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
CONTENTS
Page
Directors' report
1
Directors' responsibilities statement
2
Independent auditor's report
3 - 5
Profit and loss account
6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 20
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 1 -

The directors present their annual report and financial statements for the year ended 31 December 2022.

Principal activities
The principal activity of the company was that of the provision of facility management services for dialysis treatment to the National Health Service.
Results and dividends

The results for the year are set out on page 6.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

J Hemminger
K Lloyd
(Resigned 9 September 2022)
K Singh
M Dhaliwal
J Guerra De Almeida
(Appointed 9 September 2022)
Auditor

The company’s auditor, Mercer & Hole, incorporated on 1 October 2022 to become Mercer & Hole LLP.  The directors have consented to treating the incorporation of Mercer & Hole LLP as a continuation of the existing audit arrangement and in accordance with the company's articles, a resolution proposing that Mercer & Hole LLP be reappointed as auditor of the company will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
M Dhaliwal
Director
28 September 2023
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 2 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF DAVITA (UK) TRADING LTD
- 3 -
Opinion

We have audited the financial statements of Davita (UK) Trading Ltd (the 'company') for the year ended 31 December 2022 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 December 2022 and of its profit for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the directors' report has been prepared in accordance with applicable legal requirements.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DAVITA (UK) TRADING LTD
- 4 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit; or

  •     the directors were not entitled to take advantage of the small companies exemption from the requirement to prepare a strategic report.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Explanation as to what extent the audit was considered capable of detecting irregulaties, including fraud

We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates and considered the risk of acts by the company that were contrary to applicable laws and regulations, including fraud. These included, but were not limited to, the Companies Act 2006 and tax legislation.

We evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements and the financial report (including the risk of override of controls), and determined that the principal risks were related to posting inappropriate entries including journals to overstate revenue or understate expenditure and management bias in accounting estimates.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DAVITA (UK) TRADING LTD
- 5 -

Audit procedures performed by the engagement team included:

  • discussions with management, including considerations of known or suspected instances of non- compliance with laws and regulations and fraud;

  • gaining an understanding of management's controls designed to prevent and detect irregularities; and

  • identifying and testing journal entries.

 

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. In addition, as with any audit, there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing non- compliance and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

James Wooldridge MSci FCA
Senior Statutory Auditor
For and on behalf of Mercer & Hole LLP
28 September 2023
Chartered Accountants
Statutory Auditor
Mercer & Hole LLP
21 Lombard Street
London
EC3V 9AH
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 6 -
Year
Period
ended
ended
31 December
31 December
2022
2021
Notes
£
£
Turnover
3
20,968,291
14,892,086
Cost of sales
(10,696,891)
(7,585,766)
Gross profit
10,271,400
7,306,320
Administrative expenses
(3,208,591)
(1,934,456)
Operating profit
4
7,062,809
5,371,864
Interest payable and similar expenses
6
(24,089)
(15,917)
Profit before taxation
7,038,720
5,355,947
Tax on profit
7
(178,077)
(478,327)
Profit for the financial year
6,860,643
4,877,620

The profit and loss account has been prepared on the basis that all operations are continuing operations.

The notes on pages 10 to 20 form an integral part of the financial statements.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2022
- 7 -
Year ended
Period ended
31 December
31 December
2022
2021
£
£
Profit for the period / year
6,860,643
4,877,620
Other comprehensive income
Deferred tax credit relating to other comprehensive income
15
-
0
(5,325)
Total comprehensive income for the period / year
6,860,643
4,872,295
The notes on pages 10 to 20 form an integral part of the financial statements.
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
BALANCE SHEET
AS AT
31 DECEMBER 2022
31 December 2022
- 8 -
2022
2021
Notes
£
£
£
£
Fixed assets
Tangible assets
8
7,905,862
7,849,845
Current assets
Stocks
9
557,575
451,853
Debtors
10
9,877,403
5,010,217
Cash at bank and in hand
7,128,797
5,164,643
17,563,775
10,626,713
Creditors: amounts falling due within one year
11
(2,863,130)
(2,881,561)
Net current assets
14,700,645
7,745,152
Total assets less current liabilities
22,606,507
15,594,997
Creditors: amounts falling due after more than one year
12
-
0
(27,210)
Provisions for liabilities
Deferred tax liability
14
1,312,773
1,134,696
(1,312,773)
(1,134,696)
Net assets
21,293,734
14,433,091
Capital and reserves
Called up share capital
16
1
1
Revaluation reserve
85,188
85,188
Profit and loss reserves
21,208,545
14,347,902
Total equity
21,293,734
14,433,091

The notes on pages 10 to 20 form an integral part of the financial statements.

The financial statements were approved by the board of directors and authorised for issue on 28 September 2023 and are signed on its behalf by:
M Dhaliwal
Director
Company Registration No. 07700242
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2022
- 9 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
£
£
£
£
Balance at 1 April 2021
1
90,513
9,470,282
9,560,796
Period ended 31 December 2021:
Profit for the period
-
-
4,877,620
4,877,620
Other comprehensive income:
Tax relating to other comprehensive income
-
(5,325)
-
0
(5,325)
Total comprehensive income for the period
-
0
(5,325)
4,877,620
4,872,295
Balance at 31 December 2021
1
85,188
14,347,902
14,433,091
Year ended 31 December 2022:
Profit and total comprehensive income for the year
-
-
6,860,643
6,860,643
Balance at 31 December 2022
1
85,188
21,208,545
21,293,734

The notes on pages 10 to 20 form an integral part of the financial statements.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
- 10 -
1
Accounting policies
Company information

Davita (UK) Trading Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit 11, Greenlea Park, Prince Georges Road, London, SW19 2JD.

1.1
Reporting period

The prior period of account covers the period from 1 March to 31 December 2021 and is therefore not directly comparable.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

  • Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: The disclosure requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b), 11.48(c), 12.26, 12.27, 12.29(a), 12.29(b), and 12.29A;

  • Section 26 ‘Share based Payment’: Share based payment arrangements required under FRS 102 paragraphs 26.18(b), 26.19 to 26.21 and 26.23;

  • Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

 

The financial statements of the company are consolidated in the financial statements of Davita Inc., a company incorporated in the USA. These consolidated financial statements are available from its registered office, 2000 16th St Mall, Denver, CO 80202, USA and online with the Securities and Exchange Commission www.sec.gov.

 

1.3
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. true

 

The directors have prepared forecasts which indicate that the company can continue to trade for the foreseeable future, and they expect the business to continue to grow strongly in coming years. The ultimate parent company Davita Inc. has also agreed to provide support to the company if required.

 

The directors have, therefore, prepared the financial statements on a going concern basis.

1.4
Turnover
Turnover represents amounts receivable for facility management services net of VAT and trade discounts.
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 11 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10 -25 years (straight line)
Plant and machinery
8 -10 years (straight line)
Fixtures, fittings & equipment
5 years (straight line)
Computer equipment
3 years (straight line)

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration, including consumables, are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 12 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 13 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 14 -
1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Valuation of leasehold improvements

As described in note 8 to the Financial Statements, leasehold improvements are stated at fair value. As there is no market-based evidence of the assets their value is estimated using a depreciated replacement cost approach.

3
Turnover

An analysis of the company's turnover is as follows:

Year ended
Period ended
31 December
31 December
2022
2021
£
£
Turnover analysed by class of business
Facilities management services
17,707,963
12,657,742
Management recharges
3,260,328
2,234,344
20,968,291
14,892,086
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
3
Turnover
(Continued)
- 15 -
Year ended
Period ended
31 December
31 December
2022
2021
£
£
Turnover analysed by geographical market
United Kingdom
20,968,291
14,892,086
4
Operating profit
Year ended
Period ended
31 December
31 December
2022
2021
Operating profit for the period / year is stated after charging/(crediting):
£
£
Depreciation of owned tangible fixed assets (note 9)
983,532
788,387
Depreciation of tangible fixed assets held under finance leases (note 9)
282,233
87,816
Operating lease charges
103
(2,638)

Auditor's fees are paid by the immediate parent company.

5
Employees

The average monthly number of persons employed by the company during the period / year was:

Year ended
Period ended
31 December
31 December
2022
2022
Number
Number
Technicians
2
3

Their aggregate remuneration comprised:

Year ended
Period ended
31 December
31 December
2022
2022
£
£
Wages and salaries
158,111
119,732
Social security costs
17,476
13,577
Pension costs
3,560
2,104
179,147
135,413
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 16 -
6
Interest payable and similar expenses
Year ended
Period ended
31 December
31 December
2022
2022
£
£
Other interest on financial liabilities
24,089
15,917
7
Taxation
2022
2021
£
£
Current tax
Adjustments in respect of prior periods
-
0
2,517
Deferred tax
Origination and reversal of timing differences
178,077
286,842
Changes in tax rates
-
0
284,222
Adjustment in respect of prior periods
-
0
(95,254)
Total deferred tax
178,077
475,810
Total tax charge
178,077
478,327

The actual charge for the year/period can be reconciled to the expected charge for the year/period based on the profit or loss and the standard rate of tax as follows:

2022
2021
£
£
Profit before taxation
7,038,720
5,355,947
Expected tax charge based on the standard rate of corporation tax in the UK of 19.00% (2021: 19.00%)
1,337,357
1,017,630
Tax effect of income not taxable in determining taxable profit
(1,692)
-
0
Effect of change in corporation tax rate
-
0
284,222
Group relief
(1,119,031)
(656,061)
Permanent capital allowances in excess of depreciation
(78,789)
-
0
Other permanent differences
40,232
(74,727)
Under/(over) provided in prior years
-
0
2,517
Deferred tax adjustments in respect of prior years
-
0
(95,254)
Taxation charge for the year
178,077
478,327
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
7
Taxation
(Continued)
- 17 -

In addition to the amount charged to the profit and loss account, the following amounts relating to tax have been recognised directly in other comprehensive income:

2022
2021
£
£
Deferred tax arising on:
Revaluation of property
-
5,325
8
Tangible fixed assets
Leasehold improvements
Plant and machinery
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
£
£
Cost or valuation
At 1 January 2022
246,492
10,052,135
792,841
268,844
11,360,312
Additions
-
0
1,328,566
99,449
15,640
1,443,655
Disposals
(31,268)
-
0
(93,889)
-
0
(125,157)
At 31 December 2022
215,224
11,380,701
798,401
284,484
12,678,810
Depreciation and impairment
At 1 January 2022
45,809
3,061,057
268,776
134,825
3,510,467
Depreciation charged in the year
9,241
1,059,816
134,471
62,237
1,265,765
Eliminated in respect of disposals
-
0
-
0
(3,284)
-
0
(3,284)
At 31 December 2022
55,050
4,120,873
399,963
197,062
4,772,948
Carrying amount
At 31 December 2022
160,174
7,259,828
398,438
87,422
7,905,862
At 31 December 2021
200,683
6,991,078
524,065
134,019
7,849,845

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

2022
2021
£
£
Plant and machinery
1,302,637
556,665

Leasehold improvements were revalued by the directors at 31 March 2018. As there is no market-based evidence of the fair value of the assets their value was estimated using a depreciated replacement cost approach. The directors review the valuation each year end and have concluded that the fair value at 31 December 2022 is not materially different to the carrying value.

If revalued assets were stated on a historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
8
Tangible fixed assets
(Continued)
- 18 -
2022
2021
£
£
Cost
148,125
179,393
Accumulated depreciation
(60,236)
(50,995)
Carrying value
87,889
128,398
9
Stocks
2022
2021
£
£
Finished goods and goods for resale
557,575
451,853
10
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
1,553,271
604,779
Corporation tax recoverable
100
-
0
Amounts owed by group undertakings
7,877,420
3,858,502
Other debtors
-
0
313
Prepayments and accrued income
446,612
546,623
9,877,403
5,010,217
11
Creditors: amounts falling due within one year
2022
2021
Notes
£
£
Obligations under finance leases
13
60,155
235,653
Trade creditors
1,597,363
1,273,051
Taxation and social security
221,160
327,750
Other creditors
49,393
39,957
Accruals and deferred income
935,059
1,005,150
2,863,130
2,881,561
12
Creditors: amounts falling due after more than one year
2022
2021
Notes
£
£
Obligations under finance leases
13
-
0
27,210
DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 19 -
13
Finance lease obligations
2022
2021
Future minimum lease payments due under finance leases:
£
£
Within one year
60,530
242,707
In two to five years
-
0
27,585
60,530
270,292
Less: future finance charges
(375)
(7,429)
60,155
262,863

Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

14
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2022
2021
Balances:
£
£
Accelerated capital allowances
1,301,496
1,123,419
Revaluations
11,277
11,277
1,312,773
1,134,696
2022
Movements in the year:
£
Liability at 1 January 2022
1,134,696
Charge to profit or loss
178,077
Liability at 31 December 2022
1,312,773

The deferred tax liabilities set out above relate to accelerated capital allowances and revaluations and are expected to reverse over the lifetime of the connected assets.

DAVITA (UK) TRADING LTD
(FORMERLY RENAL SERVICES TRADING LTD)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 20 -
15
Retirement benefit schemes
Year ended
Period ended
31 December
31 December
2022
Mar 2021
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
3,560
2,104

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

16
Share capital
2022
2021
2022
2021
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary share of £1 each
1
1
1
1
17
Related party transactions

As a wholly owned subsidiary whose results are included in the consolidated financial statements of DaVita Inc, the Company has taken advantage of the exemption under FRS 102 para 33.1A, from the requirements to disclose transactions with other wholly owned group companies. Balances held at the year-end with group undertakings are shown in notes 11 and 12.

18
Ultimate controlling party

The immediate parent company is Davita (UK) Limited, a company incorporated in England and Wales.

 

The ultimate parent company is DaVita Inc., a company incorporated in Delaware, USA. This is the parent for which the consolidated financial statements are prepared. The registered office address of DaVita Inc. is 2000 16th St Mall, Denver, CO 80202, USA. The consolidated financial statements of DaVita Inc. are available online with the Securities and Exchange Commission www.sec.gov.

2022-12-312022-01-01falseCCH SoftwareCCH Accounts Production 2023.200J HemmingerK LloydK SinghM DhaliwalJ Guerra De Almeida6860643077002422022-01-012022-12-3107700242bus:Director12022-01-012022-12-3107700242bus:Director32022-01-012022-12-3107700242bus:Director42022-01-012022-12-3107700242bus:Director52022-01-012022-12-3107700242bus:Director22022-01-012022-12-3107700242bus:RegisteredOffice2022-01-012022-12-31077002422022-12-31077002422021-04-012021-12-3107700242core:RetainedEarningsAccumulatedLosses2021-04-012021-12-3107700242core:RetainedEarningsAccumulatedLosses2022-01-012022-12-3107700242core:RevaluationReserve2021-04-012021-12-3107700242core:RevenueReservesInvestmentFundsOnly2021-04-012021-12-3107700242core:ShareCapital2021-04-012021-12-31077002422021-12-3107700242core:LeaseholdImprovements2022-12-3107700242core:PlantMachinery2022-12-3107700242core:FurnitureFittings2022-12-3107700242core:ComputerEquipment2022-12-3107700242core:LeaseholdImprovements2021-12-3107700242core:PlantMachinery2021-12-3107700242core:FurnitureFittings2021-12-3107700242core:ComputerEquipment2021-12-3107700242core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3107700242core:CurrentFinancialInstrumentscore:WithinOneYear2021-12-3107700242core:Non-currentFinancialInstrumentscore:AfterOneYear2022-12-3107700242core:Non-currentFinancialInstrumentscore:AfterOneYear2021-12-3107700242core:CurrentFinancialInstruments2022-12-3107700242core:CurrentFinancialInstruments2021-12-3107700242core:ShareCapital2022-12-3107700242core:ShareCapital2021-12-3107700242core:RevaluationReserve2022-12-3107700242core:RevaluationReserve2021-12-3107700242core:RetainedEarningsAccumulatedLosses2022-12-3107700242core:RetainedEarningsAccumulatedLosses2021-12-3107700242core:ShareCapital2021-03-3107700242core:RevaluationReserve2021-03-3107700242core:RetainedEarningsAccumulatedLosses2021-03-31077002422021-03-3107700242core:LeaseholdImprovements2022-01-012022-12-3107700242core:PlantMachinery2022-01-012022-12-3107700242core:FurnitureFittings2022-01-012022-12-3107700242core:ComputerEquipment2022-01-012022-12-3107700242core:UKTax2022-01-012022-12-3107700242core:UKTax2021-04-012021-12-310770024212022-01-012022-12-310770024212021-04-012021-12-310770024222022-01-012022-12-310770024222021-04-012021-12-3107700242core:LeaseholdImprovements2021-12-3107700242core:PlantMachinery2021-12-3107700242core:FurnitureFittings2021-12-3107700242core:ComputerEquipment2021-12-31077002422021-12-3107700242core:Non-currentFinancialInstruments2022-12-3107700242core:Non-currentFinancialInstruments2021-12-3107700242core:WithinOneYear2022-12-3107700242core:WithinOneYear2021-12-3107700242core:BetweenTwoFiveYears2022-12-3107700242core:BetweenTwoFiveYears2021-12-3107700242bus:PrivateLimitedCompanyLtd2022-01-012022-12-3107700242bus:FRS1022022-01-012022-12-3107700242bus:Audited2022-01-012022-12-3107700242bus:FullAccounts2022-01-012022-12-31xbrli:purexbrli:sharesiso4217:GBP